These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19342973)

  • 1. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
    Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
    J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor vaccination effect of dendritic cells can be augmented by locally utilizing Th1-type cytokines from OK432-reactive CD4+ T cells.
    Tamada K; Harada M; Abe K; Li T; Tada H; Onoe Y; Nomoto K
    Cancer Immunol Immunother; 1998 May; 46(3):128-36. PubMed ID: 9625536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy.
    Rainone V; Martelli C; Ottobrini L; Biasin M; Texido G; Degrassi A; Borelli M; Lucignani G; Trabattoni D; Clerici M
    PLoS One; 2016; 11(1):e0146622. PubMed ID: 26795765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA.
    Teramoto K; Kontani K; Fujita T; Ozaki Y; Sawai S; Tezuka N; Fujino S; Itoh Y; Taguchi O; Kannagi R; Ogasawara K
    Cancer Immunol Immunother; 2007 Mar; 56(3):331-42. PubMed ID: 16896967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity.
    Yamaguchi S; Tatsumi T; Takehara T; Sasakawa A; Hikita H; Kohga K; Uemura A; Sakamori R; Ohkawa K; Hayashi N
    Cancer Immunol Immunother; 2008 Dec; 57(12):1861-9. PubMed ID: 18438665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine.
    Gholizadeh Z; Tavakkol-Afshari J; Nikpoor AR; Jalali SA; Jaafari MR
    J Cell Mol Med; 2018 Jan; 22(1):558-567. PubMed ID: 28944998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen presenting B cells facilitate CD4 T cell cooperation resulting in enhanced generation of effector and memory CD4 T cells.
    Kroeger DR; Rudulier CD; Bretscher PA
    PLoS One; 2013; 8(10):e77346. PubMed ID: 24155947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.
    Hotblack A; Seshadri S; Zhang L; Hamrang-Yousefi S; Chakraverty R; Escors D; Bennett CL
    Mol Ther; 2017 Feb; 25(2):504-511. PubMed ID: 28153097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current State of Dendritic Cell-Based Immunotherapy: Opportunities for
    Huber A; Dammeijer F; Aerts JGJV; Vroman H
    Front Immunol; 2018; 9():2804. PubMed ID: 30559743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studying interactions between dendritic cells and T cells in vivo.
    Chudnovskiy A; Pasqual G; Victora GD
    Curr Opin Immunol; 2019 Jun; 58():24-30. PubMed ID: 30884422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.
    Ingulli E; Mondino A; Khoruts A; Jenkins MK
    J Exp Med; 1997 Jun; 185(12):2133-41. PubMed ID: 9182685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells.
    Hüttner KG; Breuer SK; Paul P; Majdic O; Heitger A; Felzmann T
    Cancer Immunol Immunother; 2005 Jan; 54(1):67-77. PubMed ID: 15693141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Improved Antigen Uptake and Presentation of Dendritic Cells Using Cell-Penetrating D-octaarginine-Linked PNVA-co-AA as a Novel Dendritic Cell-Based Vaccine.
    Fujioka Y; Ueki H; A R; Sasajima A; Tomono T; Ukawa M; Yagi H; Sakuma S; Kitagawa K; Shirakawa T
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable contacts of naïve CD4 T cells with migratory dendritic cells are ICAM-1-dependent but dispensable for proliferation in vivo.
    Kozlovski S; Atrakchi O; Feigelson SW; Shulman Z; Alon R
    Cell Adh Migr; 2019 Dec; 13(1):315-321. PubMed ID: 31328672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-pulsed CD8alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node.
    Smith AL; Fazekas de St Groth B
    J Exp Med; 1999 Feb; 189(3):593-8. PubMed ID: 9927521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-targeted delivery of antigens using extracellular vesicles for anti-cancer immunotherapy.
    Dang XTT; Phung CD; Lim CMH; Jayasinghe MK; Ang J; Tran T; Schwarz H; Le MTN
    Cell Prolif; 2024 Jul; 57(7):e13622. PubMed ID: 38509634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tissue-like platform for studying engineered quiescent human T-cells' interactions with dendritic cells.
    Abu-Shah E; Demetriou P; Bálint Š; Mayya V; Kutuzov MA; Dushek O; Dustin ML
    Elife; 2019 Sep; 8():. PubMed ID: 31552826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of age-associated defects in dendritic cells enables CD4
    Zhivaki D; Kennedy SN; Park J; Boriello F; Devant P; Cao A; Bahleda KM; Murphy S; McCabe C; Evavold CL; Chapman KL; Zanoni I; Ashenberg O; Xavier RJ; Kagan JC
    Cell; 2024 Jul; 187(15):3888-3903.e18. PubMed ID: 38870946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.
    Dhodapkar MV; Steinman RM; Sapp M; Desai H; Fossella C; Krasovsky J; Donahoe SM; Dunbar PR; Cerundolo V; Nixon DF; Bhardwaj N
    J Clin Invest; 1999 Jul; 104(2):173-80. PubMed ID: 10411546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necroptotic-susceptible dendritic cells exhibit enhanced antitumor activities in mice.
    Zhao Z; Zhang G; Sun Y; Winoto A
    Immun Inflamm Dis; 2020 Sep; 8(3):468-479. PubMed ID: 32663380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.